The perception of the Internet as a useful resource has steadily increased among physicians since 1997, according to a study released by the Chicago-based American Medical Association.
The perception of the Internet as a useful resource has steadily increased among physicians since 1997, according to a study released by the Chicago-based American Medical Association.
The findings come from the 2001 AMA Study on Physicians' Use of the World Wide Web, in which a total of 1,001 physicians in the United States were interviewed between June 15, 2000 and September 9, 2000.
The AMA survey revealed the following trends regarding physician Internet use:
•Â A considerable increase in the use of computers among physicians (75% in 2000 from 42% in 1997) has been matched by an equally impressive increase in physician use of the Internet (70% in 2000 from 20% in 1997).
•Â The percentage of online physicians who consider the Web a useful resource for drug information (51%), business (53%) and patient education (39%) has increased significantly since 1997.
•Â Five physician activities on the Web -collecting conference information, purchasing products or services, shopping, using brokerage services, and online banking - have made large gains since 1997.
•Â Twenty-five percent of online physicians use e-mail to communicate with patients.
•Â After increasing significantly from 1997 to 1999, the proportion of physicians that have a site on the Web (26%) has stabilized.
The sample of physicians interviewed for the study was selected randomly from the AMA's Physician Masterfile, a database of information on all physicians in the United States, including members and nonmembers of the AMA. Physicians who were employed by the federal government, age 70 or older or in residency training were excluded from participation in the survey. PR
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.